FDA.reportPublic FDA data

Cleviprex 125 MG per 250 ML Injection

RxCUI
1790248
RxNorm name
Cleviprex 125 MG per 250 ML Injection
Display name
Cleviprex 125 MG per 250 ML Injection
Full name
Cleviprex 125 MG per 250 ML Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:13

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CleviprexCLEVIDIPINEFresenius Kabi Austria GmbHa6826aa3-fabb-4ff1-a7a3-cd4c34e3a3302022-11-09Warnings, Adverse reactionsExact identifier
rxcui: 1790248

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
a6826aa3-fabb-4ff1-a7a3-cd4c34e3a330Cleviprex 125 MG in 250 ML Injection [PSN] · 250 ML clevidipine 0.5 MG/ML Injection [Cleviprex] [SBD] · Cleviprex 125 MG per 250 ML Injection [SY]34These highlights do not include all the information needed to use Cleviprex safely and effectively. See full prescribing information for Cleviprex. Cleviprex (clevidipine) injectable emulsion, for intravenous use Initial U.S. Approval: 200820221109